Posts Tagged ‘IE healthcare club#8217;



Written on July 14, 2016 by Campus Life in Professional

On May 31, the IE Healthcare Club hosted Sergey Gorbatov, former IE student, current IE adjunct professor, and Development Director of Abbvie Pharmaceuticals. Sergey was able to provide us HEALTHCARE2with valuable insight into leadership opportunities in the pharma industry thanks to his experience in HR across a variety of companies.

 Sergey began his talk with the most important element of the industry: the patient. Abbvie is committed to patient-centered development and this mindset is crucial to leadership, research, and development in the company. Abbvie focuses in bio-pharma and seeks to tackle some of the most serious health issues such as liver disease and cancer. Particularly exciting are Abbvie’s current investments in an all-oral interferon-free treatment for hepatitis C and difficult-to-treat cancers such as multiple myeloma.  

 An interesting insight Sergey shared with us was to look for companies that invest in drugs for rare and hard-to-treat diseases. These so-called “orphan drugs” are a good indicator of a company’s innovation environment and future viability, Sergey explained. While it may seem counter-intuitive to seek leadership opportunities in big pharma, companies like Abbvie that prove their commitment to R&D and encourage idea-sharing at all levels of the organization can deliver results and make a powerful impact in patients’ lives.


Students from the IMBA, MIM, and Big Data programs attended and participated in the discussion followed by an informal networking event with Sergey.


Future Trends in Healthcare

Written on July 13, 2016 by Campus Life in Professional

healthcareOn June 14, 2016, the IE Healthcare Club hosted Juan Manuel Martín to discuss the future of healthcare across several industries. He is currently the Innovation Director at Doublethink SL and has many years of experience in healthcare at Pfizer among other companies.

Juan noted several emerging trends that will have a major impact on the healthcare industry for years to come. These included population growth, population aging, genetically-tailored treatments in personalized medicine, and the role of big data analytics in health.

As the population increases in many countries, public health costs will rise and cost-saving measures will only become more important. The group also discussed advances in technology and how these are reshaping the healthcare industry. Many companies are exploring personalized medicines rather than one-size-fits-all treatments. Finally, data analytics can play a role in health in the future by aiding medical professionals to quickly diagnose illnesses and track epidemics efficiently.

Students from the IMBA, MIM, and Big Data programs attended and participated in the discussion followed by an informal networking event with our speaker.

We use both our own and third-party cookies to enhance our services and to offer you the content that most suits your preferences by analysing your browsing habits. Your continued use of the site means that you accept these cookies. You may change your settings and obtain more information here. Accept